Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-06.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
Thymopentin Therapy in Atopic Dermatitis

Journal of the Korean Pediatric Society 1998;41(9):1268-1272.
Published online September 15, 1998.
Thymopentin Therapy in Atopic Dermatitis
Geun Woong Noh1, Ki Young Lee2
1Departments of Pediatrics, College of Medicine, Sungkyunkwan University, Samsung CheilHospital and Women`s Healthcare Center, Seoul, Korea
2Departments. of Pediatrics, Yonsei University, College of Medicine, Seoul, Korea
아토피 피부염의 Thymopentin 치료
노건웅1, 이기영2
1성균관대학교 의과대학 삼성제일병원 소아과
2연세대학교 의과대학 소아과학교
Correspondence: 
Geun Woong Noh, Email: 1
Abstract
Purpose
: Atopic dermatitis is a chronic relapsing inflammatory skin disease that results from allergic reaction. Steroid therapy has become a major therapeutic modality for treatment of atopic dermatitis. Several immunomodulatory therapies have been tried for atopic dermatitis. In this study thymopentin therapy was performed and its clinical effects and laboratory results were evaluated.
Methods
: Atopic dermatitis with typical clinical symptoms were included in this study. Twelve patients were treated with subcutaneous injection of thymopentin((ImupentinⓇ) at a dose of 1 mg/kg, three times per week for eight weeks. Clinical scores were measured by Hanifin scoring system before and at the end of the treatment. General hematologic laboratory tests such as hemoglobin, hematocrit, WBC count, neutrophil percentage, lymphocytes percentage and eosinophil percentage as well as blood IgE level were conducted at the same time.
Results
: The clinical severity of atopic dermatitis patients was markedly improved by thymopentin therapy. The clinical severity score improved by 85.5%. Three patients showed complete remission of clinical status at the end of thymopentin therapy. Hemoglobin, hematocrit, WBC counts, neutrophil percentage, and lymphocyte percentage were not affected by the thymopentin therapy. Eosinophil percentage and blood IgE level were significantly reduced statistically.
Conclusion
: Thymopentin therapy is an effective immunomodulatory therapeutic modality in atopic dermatitis. Thymopentin decreased eosinophil percentage and blood IgE levels without other hematologic changes.
Key Words: Thymopentin, Eosinophil, IgE, Atopic dermatitis


METRICS Graph View
  • 2,134 View
  • 24 Download